First day of trading in warrants of series TO1 and TO2 has been set for October 14, 2020
As previously announced, Cereno Scientific AB (”Cereno” or the ”Company”) has carried out a directed issue of shares and warrants of series TO1 and TO2 with issue funds of approximately SEK 60 million (the “Directed Issue”). In addition to the Directed Issue, the Company has simultaneously issued warrants of series TO1 and TO2 granted to (i) the Companys’s existing shareholders as compensation for the dilution caused by the Directed Issue and to (ii) Formue Nord Fokus A/S in its capacity as lender. The Company hereby announces that the first day for trading for the warrants of series TO1 and